Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of HFT-290 Fentanyl Citrate Patch for Cancer Pain
jRCT2080223308Phase 3
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Sep 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fentanyl in cancer pain, sponsored by Hisamitsu Pharmaceutical Co., Inc.
02
Drugs
fentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT2080223308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223308.